Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure

Research output: Contribution to journalLetterResearchpeer-review

Abstract

Expanding disease definitions are one driver of overdiagnosis and related overtreatment.1 In November 2017, new guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) expanded the definition of hypertension, extending the label to 46% of adults in the United States.2 The expanded definition was welcomed by some as an important public health initiative; however, other national and international groups, including the American Academy of Family Physicians, did not endorse the expanded definition amid concerns about potential harms.3 Concerns raised included potential overtreatment; intellectual conflicts of interest held by some of the panel members involved with the new ACC/AHA guideline, including members who were connected to a major trial that strongly influenced the guideline; and uncertainty regarding blood pressure measurement methods. A checklist-based analysis found that most people newly classified as hypertensive were unlikely to benefit, but instead could experience harms from being unnecessarily labeled as having hypertension, and some people could experience adverse effects from unnecessary medication.4 We investigated how the media covered the potential benefits and harms of the expanded definition of hypertension.
Original languageEnglish
Pages (from-to)272-273
Number of pages2
JournalJAMA Internal Medicine
Volume179
Issue number2
Early online date28 Dec 2018
DOIs
Publication statusPublished - 1 Feb 2019

Fingerprint

Guidelines
Hypertension
American Heart Association
Conflict of Interest
Family Physicians
Cardiology
Checklist
Uncertainty
Public Health
Blood Pressure
Medical Overuse

Cite this

@article{4cc91d46abbf4057a9bc92a87732f117,
title = "Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure",
abstract = "Expanding disease definitions are one driver of overdiagnosis and related overtreatment.1 In November 2017, new guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) expanded the definition of hypertension, extending the label to 46{\%} of adults in the United States.2 The expanded definition was welcomed by some as an important public health initiative; however, other national and international groups, including the American Academy of Family Physicians, did not endorse the expanded definition amid concerns about potential harms.3 Concerns raised included potential overtreatment; intellectual conflicts of interest held by some of the panel members involved with the new ACC/AHA guideline, including members who were connected to a major trial that strongly influenced the guideline; and uncertainty regarding blood pressure measurement methods. A checklist-based analysis found that most people newly classified as hypertensive were unlikely to benefit, but instead could experience harms from being unnecessarily labeled as having hypertension, and some people could experience adverse effects from unnecessary medication.4 We investigated how the media covered the potential benefits and harms of the expanded definition of hypertension.",
author = "Moynihan, {Raymond Noel} and Justin Clark and Loai Albarqouni",
year = "2019",
month = "2",
day = "1",
doi = "10.1001/jamainternmed.2018.6201",
language = "English",
volume = "179",
pages = "272--273",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "AMER MEDICAL ASSOC",
number = "2",

}

Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure. / Moynihan, Raymond Noel; Clark, Justin; Albarqouni, Loai.

In: JAMA Internal Medicine, Vol. 179, No. 2, 01.02.2019, p. 272-273.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure

AU - Moynihan, Raymond Noel

AU - Clark, Justin

AU - Albarqouni, Loai

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Expanding disease definitions are one driver of overdiagnosis and related overtreatment.1 In November 2017, new guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) expanded the definition of hypertension, extending the label to 46% of adults in the United States.2 The expanded definition was welcomed by some as an important public health initiative; however, other national and international groups, including the American Academy of Family Physicians, did not endorse the expanded definition amid concerns about potential harms.3 Concerns raised included potential overtreatment; intellectual conflicts of interest held by some of the panel members involved with the new ACC/AHA guideline, including members who were connected to a major trial that strongly influenced the guideline; and uncertainty regarding blood pressure measurement methods. A checklist-based analysis found that most people newly classified as hypertensive were unlikely to benefit, but instead could experience harms from being unnecessarily labeled as having hypertension, and some people could experience adverse effects from unnecessary medication.4 We investigated how the media covered the potential benefits and harms of the expanded definition of hypertension.

AB - Expanding disease definitions are one driver of overdiagnosis and related overtreatment.1 In November 2017, new guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) expanded the definition of hypertension, extending the label to 46% of adults in the United States.2 The expanded definition was welcomed by some as an important public health initiative; however, other national and international groups, including the American Academy of Family Physicians, did not endorse the expanded definition amid concerns about potential harms.3 Concerns raised included potential overtreatment; intellectual conflicts of interest held by some of the panel members involved with the new ACC/AHA guideline, including members who were connected to a major trial that strongly influenced the guideline; and uncertainty regarding blood pressure measurement methods. A checklist-based analysis found that most people newly classified as hypertensive were unlikely to benefit, but instead could experience harms from being unnecessarily labeled as having hypertension, and some people could experience adverse effects from unnecessary medication.4 We investigated how the media covered the potential benefits and harms of the expanded definition of hypertension.

UR - http://www.scopus.com/inward/record.url?scp=85059232267&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2018.6201

DO - 10.1001/jamainternmed.2018.6201

M3 - Letter

VL - 179

SP - 272

EP - 273

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 2

ER -